th world congress on breast cancer · breast-sparing surgery symptoms of breast cancer in men...
TRANSCRIPT
April 25-26, 2019London, UK
Breast Cancer9th World Congress on
S C I E N T I F I C P R O G R A M
conferenceseries.com
SCIENTIFIC PROGRAM
Thursday, 25th April DAY 1Thursday, 25th April
08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50 Meeting Hall 01
KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On: Breast Cancer Therapy , Prevention and Medicine
Talks On: Screening, Detecting and Diagnosing Breast Cancer
Chemotherapy, Hypnotherapy, Radiation Therapy Breast Magnetic Resonance Imaging
Early & Advanced Breast Cancer Systemic Therapy Mammography
Breast Reconstruction Therapy Clinical Breast Exam and Breast self-exam
Treatment of Breast Cancer During Pregnancy Breast Ultrasound
Pros and Cons of Breast Cancer Screening
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00 Talks On: Surgery Choices for Breast Cancer Talks On: Male Breast Cancer
Breast-Sparing Surgery Symptoms of Breast Cancer in Men
Breast-Conserving Surgery or Mastectomy Risk Factors for Breast Cancer in Men
Lymph Node Surgery Familial Predisposition
Breast Reconstruction Surgery Staging and Diagnosis
Tissue Flap Surgery Protein Biochemistry
Mass spectrometry techniques Protein Interaction
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Breast Cancer Workshop
Visit: https://breastcancer.conferenceseries.com/
SCIENTIFIC PROGRAM
Friday, 26th April DAY 2Friday, 26th April
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Breast Cancer Nursing
Talks On: Immunology and Breast Cancer
Professional and Ethical Understanding of Patients Immune Response
Assessment and Management of Patients Breast Carcinoma and Immunity
Multidisciplinary Care Immune Reaction towards Breast
Values and Attitudes in relation to the care Tumor Antigens
Psychological Support Immunotherapy
Molecular diagnostics for infectious disease Self Antigens
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Alternative and Complementary Medicine
Talks On: Current and Future State
Conventional and Alternative Medicine Radiotherapy and Novel Agents in Combination
Spirituality, Religion and Complementary Medicine
Techniques to Lower the side effects of Radiotherapy
Meditation, Massage, Acupuncture and Herbs Challenges
Optimization of Combined Treatment Surgical Treatment
Intake of Supplements Screening Methods
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Poster Presentations Workshop
Visit: https://breastcancer.conferenceseries.com/
9th World Congress
on Breast Cancer
April 25-26, 2019 | London, UK
AGENDA
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Dr. Geert C. Mudde received a Ph.D. in immunology from the University of
Utrecht in 1985 and started his international professional career at the Swiss Institute for Asthma and Allergy Research in Davos in 1989. In 1992 he joined
the pharmaceutical/biotech industry, where he held several senior
management positions at the Novartis Research Institute in Vienna, Austria, the Parke Davis Research Institute in Fresnes, France, Ingenium
Pharmaceuticals, Martinsried, Germany, and at igeneon AG, Vienna, Austria.
Finally, in 2006, while joining Baxter BioScience in Vienna as interim manager, Dr. Mudde co-founded the biotech company f-star Biotechnology,
where he served as “Chief Scientific Officer” from 2007 to 2009.
Dr Geert C. Mudde
OncoQR ML GmbH,
Austria
Dr. Kim O’Neill completed his PhD at the University of Ulster in the Biomedical Sciences Research Center. He was recruited to Brigham Young University, in Provo
Utah in 1992. He has published over 140 peer reviewed papers, and presented his
research at numerous international meetings. Dr. O’Neill is a member of the American Association for Cancer Research (AACR), and currently serves on the
AACR Science Education committee.
Dr. Kim O’Neill
Brigham Young
University
USA
Dr. Mark graduated Phi Beta Kappa and Summa Cum Laude from Yale University. He received his Medical Degree from UCLA and also completed his residency in
Radiation Oncology at UCLA. He has published or presented more than 250 papers
or abstracts at peer-reviewed national and international meetings. Baylor Scott & White
Medical Center, USA
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Prof P.A. Cohen is Full Professor in Molecular Biology and Biotechnology in the
Faculty of Pharmacy of the University of Lyon, France since 2005. She is also
Principal Investigator and manages a team in the CRCL Cancer Research Center
of Lyon CRCL UMR INSERM 1052-CNRS 5286, France. She got a degree in
Pharmacy (1991), a PhD in Biomedical Sciences (1995, Univ. Montpellier,
France). She was Post-doctoral fellow in the Cancer Research Campaign
Laboratories, University of Dundee, Scotland, U.K. (1996-98, Advisor: Sir Prof.
D.P. Lane, F.R.S.). She got several honors such as Exceptional Class Professor
Distinction and her research work has been awarded by many prizes. She is also
committed in several national and international education programs and is
frequently requested as external scientific referee for international scientific
journals or committees.
Centre de Recherche en
Cancérologie de Lyon,
France
Dr.Abouelnagah born in Alexandria, Egypt and did his Medical Studies at Alexandria University. He had Master Degree in Colorectal surgery 1993, FRCS
Glasgow and FRCS Edinburgh 1999, Diploma in Laparoscopy from Europian
Surgical Institute, Germany, August 2000, MD surgical oncology from Alexandria Univerisity, July 2003, MBA in hospital management:, February 2010
and lastly FRCS London, Sep 2010. In 1995 he worked as a senior registrar at
Jeddah, Saudi Arabia, in 1996 he became assistant lecturer at Alexandria
University.
Alexandria University
Egypt
Hend has completed her MSc in nursing at the age of 31 years from the
Royal College of Surgeons in Ireland with a first class honor degree. She
has more than 8 years experience in the field of nursing and is the charge
nurse of oncology OPD in SKSH which is one of the well known hospitals
offering oncology care in the UAE. She has reported her Msc dissertation in
two international conferences.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Dr. Tanay N. Shah is a surgical oncologist. He has pursued his academic
qualifications from several reputed institutes.MBBS from Govt. Medical College,
Baroda (M.S. university), India M.S. in General Surgery from Govt. Medical
College, Baroda (M.S. university), India FMAS(Fellowship in Minimal Access
Surgery) from SMIMER, Surat, India . DNB – Surgical Oncology from Bhagwan
Mahaveer Cancer Hospital & Research Center, Jaipur, India
Bhagwan Mahaveer
Cancer Hospital &
Research Centre,
India
The nurse has her expertise in evaluation and passion in improving the health and
wellbeing.She has built this model after years of experience in research, evaluation,
teaching and administration both in hospital and education institutions.
Medical oncologist specialist in systemic treatment (chemotherapy, hormone
therapy, white therapy, immunotherapy) for cancer. The treatment is totally
individualized and depends on multiple factors. During the consultation, imaging,
laboratory and pathology studies are evaluated to provide the best option.
Delgado-Salgado
Daniela, Mexico
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Dr.ABOUELNAGAH born in Alexandria, Egypt and did his Medical Studies at
Alexandria University. He had Master Degree in Colorectal surgery 1993, FRCS
Glasgow and FRCS Edinburgh 1999, Diploma in Laparoscopy from Europian
Surgical Institute, Germany, August 2000, MD surgical oncology from
Alexandria Univerisity, July 2003, MBA in hospital management:, February 2010 and
lastly FRCS London, Sep 2010. In 1995 he worked as a senior registrar at Jeddah,
Saudi Arabia, in 1996 he became assistant lecturer at Alexandria University Surgical Alexandria University
Egypt
Styliani Parpoudi completed her MSc in 2014 from Democritus University of Thrace
and she is currently in the process of submitting her doctoral dissertation from
Aristotle University of Thessaloniki. She completed her specialty training in General
Surgery in 2017 at the 4th University Department of General Surgery of Aristotle
University of Thessaloniki and, for the last 2 years, she is working as a consultant in
the Surgical Oncology Breast Unit of ‘Theagenio’ Cancer Hospital in Thessaloniki.
She has published 11 papers in reputed national and international magazines and she
has participated as a speaker in 12 national and international congresses.
In 2006 she was admitted into Akim-oda community health nursing training
school and completed successfully. She was posted to ST John of God hospital in
the Tano north district Brong-Ahafo in 2009. She worked as a community health
nurse for three years. In 2014 She completed midwifery nursing training from
Goaso. She was then reposted to another district thus Asutifi north and at the
district was send to work at krakyekrom CHPS compound as a midwife.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Manal Malki is a Masters student at King Saud University.She has undertaken this
research Project under the supervision of well known Dr.Samina Hyder Haq. Her
studies are of great value and importance for the scientific community as her
conclusive Molecular Biology Experements revealed a direct relationship of the gene
expression of Bcl-2/Bax ratio in the etiology of Breast cancer and possibility of using
Melatonin and Vitamin D3 along with Timoxifen could greatly increase the efficacy
and better strategy to treat Breast Cancer.
Nora Saad Alkeraishan is a Masters students at King Saud University, Riyadh Saudi
Arabia.She undertook this Research Project under direct supervision of well known
Scientist Dr. Samina Hyder Haq. Her intersting studies on the effect of Melatonin and
Vitamin D3 on Breast Cancer Cell line MCF-7 revealed that Melatonin could
significantly upregulate p53 gene expression in cultured cells and observed no direct
relatioship of Vitamin D3 in upregulating p53 gene expression. Currently she is
involved in genotyping the p53 to detect mutations present in the gene itself.
Wakeel Adelani Tijani is a Professor of Nursing, Public Health specialty. He has over
20 year working experience. He has worked as bed-side nurse, tutor at basic school of
nursing and lecturer departments of nursing in universities. He started his lectureship
career at Ladoke Akintola University of Technology Ogbomoso in 2003 as an
Assistant Lecturer, and rose steadily to full Professor of Nursing at Bayero University
Kano in 2015. He has occupied many leadership posts in nursing. He has over 50
publications to his credit. He has attended many conferences, local and international,
where he presented papers on health issues.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Adejumoke SANUSI is a registered nurse, registered midwife, registered public
health nurse. She is a BNSc and MSc (Nursing science) graduate. She has worked in
the hoapital settings for some years before joining the university system four (4) years
ago. She has twelve (12) published articles. She has attended national and
international conferences.
Petra El Hajj has completed his PhD on 2015 from Lebanese university and
Universite Libre de Bruxelles, where she has published 4 articles on TYRP1
expression and regulation in melanoma, among them two in the “British journal of
cancer”. Nowadays, she is a lecturer at Lebanese University, faculty of sciences, and a
researcher in the same institution in the field of triple negative breast cancer in female
Lebanese patients.
Prakash Kinthada is a Professor in Chemistry at Sri Vidyanikethan Engineering
college, JNTU University in Ananthapur, A. Rangam Peta, Tirupathi, India.
SP
EAK
ER S
LOT
S A
VA
ILA
BLE
Ms. Divya Bakshi is currently pursuing her Ph.D. from Shri Mata Vaishno Devi
University, India, and is currently in her 4rth year of Ph.D. work.
Nora Klöting is from University of Leipzig , Specialisation is IFB AdiposityDiseases.
Wassil Nowicky Nowicky Pharma, Austria
Peter Onneken Institute of Diet and Health, Germany
Yoko Matsumoto Sojo University, Japan
Manuela Lacerda IPATIMUP, Portugal
Imrana Masroor Aga Khan University Hospital, Pakistan
Maryam Mansoori Iran University of Medical Sciences, Iran
Olaf G Wilhelm Therawis Diagnostics GmbH, Germany
Ratna Parikh Breach Candy Hospital, India
Alicia González González Cantabria University, Spain
Javier Menéndez Menéndez University of Cantabria, Spain
Maria Inês Branco Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
Peter Sandbichler Hospital St.Vinzenz, Austria
Vuka V Katic Human Policlinic,Serbia
Stefan Glück Celgene Corporation,USA
Hiltrud Brauch Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany
Baris Cankaya University Pendik Training Hospital, Turkey
Gul Cankaya University Pendik Training Hospital, Turkey
Jack Sariego Aria-Jefferson Health System, PA USA
Ashutosh Kothari Guys Hospital,UK
Hong Zhang University of Texas-M D Anderson Cancer Center, USA
Yun Gong MD Anderson Cancer Center, USA
Hongying He The University of Texas Medical School at Houston,USA
Jill Hervik Vestfold Hospital Trust, Norway
Valerijus Ostapenko
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://breastcancer.conferenceseries.com/
National Cancer Institute,Lithuania
Ashmitha Srinivasan MD Anderson Cancer Center, TX USA
Carole Verhoeven Pantarhei Bioscience,The Netherlands
Jana Slobodníková Alexander Dubček University in Trenčín, Slovak republik
Marike Gabrielson Karolinska Institutet,Sweden
Sakina E. Elto Meharry Medical College,USA
Steven M. Hill Tulane University, USA
Lloyd Jenkins Budwig Center, Spain
Sarah Spiegel Virginia Commonwealth University, USA
Sheldon Milstien Virginia Commonwealth University, USA
Cohen-Armon Tel-Aviv University,Turkey
Anne Ryhänen University of Turku, Finland
Shikai Wu Affiliated Hospital of Academy of Military Medical Sciences,China
Hale AYDIN
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital,Turkey
Guan Chen Medical College of Wisconsin, USA
Kim Jaffee Wayne State University, USA
Lidija Covic Tufts Medical Center, USA
Shahla Masood Medical Director, UF Health Breast Center, USA
M.P. van den Tol University Medical Center De Boelelaan , The Nederlands
Gaiane M. Rauch UT MD Anderson Cancer Center, USA
Michael Thompson University of Wroclaw, Canada
Emmanuelle Charafe-Jauffret University of Mediterranée, France
Daphne Gschwantler-Kaulich Medical University of Vienna, Austria
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://breastcancer.conferenceseries.com/
PAST AFFILIATES Jun Yang St Jude Children’s Research Hospital, USA
Antonio Carlos Wolff The Johns Hopkins University , USA
Linda A. deGraffenried The University of Texas at Austin, USA
Chang Gong Sun Yat-Sen University, China
Marco Bernini Careggi University Hospital,Florence, Italy
Ragheed Al-Mufti The West of London Breast Cancer Network, UK
Maude Hébert University of Quebec in Trois-Rivieres, Canada
Giorgio Berna Director Regional Hospital of Treviso, Italy
Prof. C C Busby Professor & Director Environmental Research SIA, United Kingdom
Fraid Meybodi Breast and Endocrine Surgeon Westmead Hospital , Australia
Peter Weightman Professor University of Liverpool, United Kingdom
Amila Orucevic Associate Professor University of Tennessee Medical Center , USA
Kiven Erique Lukong
Associate Professor University of Saskatchewan, Canada
San Ming Wang Associate Professor University of Nebraska, USA
Federico Cattin Breast Surgeon Sterzing General hospital, Italy
Matthew Curzon Pathology Resident University of Tennessee Medical Center , USA
Raj Kumar Professor The Commonwealth Medical College, USA
Philippa Darbre Associate Professor University of Reading, United Kingdom
Anne Marie Lunde Husebø Assistant Professor University of Stavanger, Norway
Syeda Zakia Hossain Senior Lecturer The University of Sydney, Australia
Susan J Done Associate Professor University of Toronto, Canada
PAST
AFF
ILIA
TES
Visit: https://breastcancer.conferenceseries.com/
PAST AFFILIATESIgor Buchwalow Professor University of Muenster, Germany
Thomas Kieber-Emmons Professor University of Arkansas for Medical, Scien, USA
Stefan B. Eichmüller Professor German Cancer Research Center, Germany
Guldeniz Karadeniz Cakmak Associate Professor Bulent Ecevit University, Turkey
Diptendra K Sarkar Professor IPGMER, India
Nicolae Bacalbasa Professor Fundeni Clinical Institute, Romania
Werner Boecker Professor University of Muenster, Germany
Mihaela Lorger Group Leader University of Leeds, United Kingdom
Tibor tot Associate Professor University of Uppsala, Sweden
John Bell Professor of Surgery University of Tennessee Medical Center, USA
Aysegul A. Sahin Professor & Director The University of Texas, USA
Graham Ross Roche Products Limited, Herts, United Kingdom
Vicente Marco Director Hospital Quirón Barcelona, Spain
Sidharth Sahni Breast surgeon Indraprastha Apollo Hospital, India
Lei Huo Associate Professor MD Anderson Cancer Center, USA
Yvonne Paterson Professor University of Pennsylvania, USA
Daniel Snyder Pathology Resident University of Tennessee Medical Center , USA
Heather Gage Pathology Resident University of Tennessee Medical Center, USA
PAST
AFF
ILIA
TES
Visit: https://breastcancer.conferenceseries.com/
London Attractions
Lond
on Eye
Big Ben
British
Mus
eum
Tower
Brid
ge
The
Shar
d
War
ner B
ros.
Stud
io
Tower
of L
ondo
n
Mad
ame
Tuss
auds
Sea
Life
Lond
on
Glimpses ofBreast Cancer Conferences
Visit: https://breastcancer.conferenceseries.com/
conferenceseries.com1614th Conference
M a y 1 0 - 1 1 , 2 0 1 8 | F r a n k f u r t , G e r m a n y
Scientific Program
UK: Conference Series llc LTD47 Churchfield Road, London, W3 6AY
Toll Free: +0-800-014-8923
7th World Congress on Breast Cancer
Page 13
RegistrationsDay 1 May 10, 2018
Keynote ForumIntroductionTitle: The antiangiogenic properties of NSC-631570 (Ukrain) on breast cancerWassil Nowicky, Nowicky Pharma/ Ukrainian Anti-Cancer Institute, AustriaTitle: Endocrine treatment of breast cancer: current concepts to predict and prevent relapseHiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, GermanyTitle: Title:Immuno-Oncology in Breast cancer: early promise?Stefan Glück, Celgene Corporation, USA
Group Photo
Networking and Refreshments Break FoyerSessions: Screening, Detecting and Diagnosing Breast Cancer | Breast Cancer Therpy , Prevention and MedicineSession Chair: Wassil Nowicky, Nowicky Pharma/ Ukrainian Anti-Cancer Institute, Austria Session Co-Chair: Ratna Parikh, Breach Candy Hospital, IndiaTitle: Concerning the changing of diagnostic approach, guidelines, role and importance on decision of the different medical specialties involved ( in the last 30 years) in the setting of a screening and treatment reference hospital Manuela Lacerda, IPATIMUP, PortugalTitle: Melatonin enhances chemosensitivity of human endothelial and breast cancer cells by regulating genes involved in angiogenesisAlicia González González, University of Cantabria, Spian
Lunch Break @ Rastaurant palate friendTitle: Effects of melatonin on chemotherapy treatments in gene expression and proteomics of human breast cancer Javier Menéndez Menéndez, University of Cantabria, SpianTitle: Blocks for relieving pain associated with breast surgeryBaris Cankaya, Marmara University Pendik Training Hospital, TurkeyTitle: The breast-q in perioperative period for breast conserving surgery: how patient reported outcome measures contribute to health related quality of life Gul Cankaya, Marmara University Pendik Training Hospital, Istanbul/ TurkeyTitle: Experiences in organisation of Breast cancer facilities in rural IndiaRatna Parikh, Breach Candy Hospital , Mumbai, IndiaTitle: Giant inflammatory myofibroblastic tumor of the breast case report and review of literatureVuka V Katic, Human Policlinic, Serbia
Networking and Refreshments Break @ FoyerTitle: Accuracy of the specimen radiography in the breast-conservation surgeryImrana Masroor, Aga Khan University Hospital Karachi, PakistanTitle: Adjuvant endocrine monotherapy for postmenopausal early breast cancer patients with hormone-receptor positive: a systemic review and network meta-analysisHaitian Zhang, First Affiliated Hospital of Guangxi Medical University, ChinaTitle : Nutrition and breast cancer rates in high and low happiness countriesLyudmila Radkevich, Russian Academy of Sciences, Moscow, Russia
Panel Discussion Day 2 May 11, 2018
Conference Hall-Taunus
Opening Ceremonyconferenceseries.com
Conference Hall-Taunus
Page 14
Keynote ForumIntroductionTitle: The Impact of Salvia hispanica l. enhanced nutrition on breast cancer preventionPeter Onneken, Institute of Diet and Health, Germany
Networking and Refreshments Break @ FoyerTitle: Therapeutic effects of trehalose liposomes against breast tumors along with ApoptosisMatsumoto Yoko, Japan Nanomedicine Society , JapanSessions: Surgery Choices for Breast Cancer | Screening, Detecting and Diagnosing | Breast Cancer Breast Cancer Therpy , Prevention and MedicineSession Chair: Peter Onneken, Institute of Diet and Health, GermanySession Co-Chair: Peter Sandbichler, St.Vinzenz, AustriaTitle: A predictive model to identify who would benefit from primary tumor surgery among patients with metastatic breast cancer at diagnosis: a population-based analysisLingxiao Zhang, Xi’an Jiaotong University, ChinaTitle: Immediate breast reconstruction with laparoscopic harvested omental flap after breast cancer surgeryPeter Sandbichler, Department of surgery, Hospital St.Vinzenz, Austria
Lunch Break @ Rastaurant palate friendTitle: Breast cancer: Correlation of ultrasonographic features with molecular subtypeMaria Inês Branco, Centro Hospitalar Vila Nova de Gaia/Espinho, PortugalTitle: PITX2 DNA-methylation, a Novel Validated Predictive Marker In High-Risk Breast Cancer Patients to Assess the Benefit of Anthracycline-Based Chemotherapy Olaf G. Wilhelm, Therawis Pharma GmbH, GermanyTitle: Role of mammary gland stem/progenitor cells in tumorigenesisLuZhe Sun, University of Texas Health Science Center, USATitle: Preoperative ultrasound guided biopsy of axillary nodes for staging in patients with clinically negative axilla – in a tertiary care center in a third world countryImrana Masroor, Aga Khan University Hospital Karachi, PakistanTitle: Expression of ganglioside GD2, as a novel cancer stem cell marker in breast carcinomas.Maryam Mansoori, Iran University of Medical Sciences, Iran
Networking & Refreshments Break @ Foyer Poster Presentations @ Foyer
WCBC 001Title: Natural killer cell functionality is impaired by diet-induced obesity in a postmenopausal breast cancer mouse modelJulia Spielmann, Martin Luther University Halle-Wittenberg, Germany
WCBC 002Title: A case report of cerebral venous thrombosis after taking tamoxifen in breast cancer patientKitwadee Saksornchai Athigakunagorn, King Chulalongkorn Memorial Hospital, Thailand
WCBC 003Title: PIM1: A promising target in patients with triple negative breast cancerZhao Wen, Xi’an Jiaotong University, China
WCBC 004Title: Effects of Paeonia lactiflora on the Hs00 gene expression in triple negative breast cancer cellsJou-An Chen, National Yang-Ming University, Taiwan
Panel Discussion Award Ceremony
conferenceseries.com
UK: Conference Series llc LTD47 Churchfield Road, London, W3 6AY
Toll Free: +0-800-014-8923
June 15-17, 2017 London, UK
5th World Congress on
Breast Cancer
Scientific Program977th Conference
RegistrationsDay 1 June 15, 2017
Keynote ForumIntroductionTitle: Role of sphingosine-1-phosphate in estrogen receptor signaling in breast cancerSarah Spiegel, Virginia Commonwealth University School of Medicine, USATitle: Biomarkers that have prognostic and therapeutic importance for inflammatory breast cancer Yun Gong, University of Texas-M D Anderson Cancer Center, USA
Group Photo & Networking & Refreshments Break @ Foyer Sessions: Breast Cancer Therapy, Prevention and Management | Breast Cancer-Present Perspective | Breast Cancer NursingSession Chair: Steven M Hill, Tulane University School of Medicine, USASession Co-chair: Manjeet Rao, University of Texas Health Science Center, USA
Session IntroductionTitle: FOXK2 aberration in breast cancersAmy Hong Zhang, University of Texas-M D Anderson Cancer Center, USATitle: Circadian/melatonin disruption by dim light at night drives human epithelial breast cancer to a metastatic phenotypeSteven M Hill, Tulane University School of Medicine, USATitle: The impact of Nolvadex to generic tamoxifen switch on side effects and patient compliance in hormone receptor positive breast cancer patientsBashar Zeidan, Royal Hampshire County Hospital, UKTitle: Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysisJill Brook Hervik, Vestfold Hospital Trust, NorwayTitle: Volkmann’s breast operation (modified radical mastectomy) and its value in modern treatment of breast cancer Valerijus Ostapenko, National Cancer Institute, Lithuania
Lunch Break @ RestaurantTitle: Exhibitor presentation By Sophiagenetics SAGerald Martin, Sophiagenetics SA, SwitzerlandTitle: The use of high dose estrogens for the treatment of breast cancerCarole Verhoeven, Pantarhei Oncology BV, The NetherlandsTitle: Exclusive self-destruction of triple negative breast cancer cellsCohen-Armon, Tel-Aviv University, IsraelTitle: A functional cross-talk between GPER and IGF1/IGF1R signaling drives breast tumor angiogenesis via activation of the HIF-1α/VEGF transduction pathway Ernestina Marianna De Francesco, University of Manchester, UK
Networking & Refreshments Break @ FoyerTitle: FoxM1 inhibition: A novel therapeutic avenue to treat breast cancers Manjeet Rao, University of Texas Health Science Center, USATitle: The effect of Internet-based breast cancer patient’s pathway on breast cancer patients’ empowering processAnne Ryhanen, The University of Turku, FinlandTitle: Relationships among body mass index, systemic immune-inflammation index and luminal subtype in the resistance to endocrine therapy of breast cancerQingxia Li, Hebei General Hospital, China
Panel Discussions
Opening Ceremonyconferenceseries.com
Conference Hall- Waterfront 1
Day 2 June 16, 2017Conference Hall- Waterfront 1
Keynote ForumTitle: Endocrine treatment of breast cancer: Current concepts to predict and prevent relapseHiltrud Brauch, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, GermanyTitle: Naturopathic doctor in complementary natural treatment and prevention of cancerLloyd Jenkins, Budwig Center, SpainSessions: Screening, Detecting, and Diagnosing Breast Cancer | Surgery Choices for Breast Cancer | Personalized Medicine for Breast Cancer TreatmentSession Chair: Uhi Toh, Kurume University School of Medicine, JapanSession Co-chair: Anne Ryhanen, The University of Turku, Finland
Session IntroductionTitle: Comparison of bilateral whole-breast ultrasonography versus magnetic resonance imaging in the setting of breast cancer stagingHongying He, University of Texas Health Science Center at Houston, USA
Networking & Refreshments Break @ FoyerTitle: Oncoplastic and reconstructive surgery single institution experienceZhygulin Andrii, LISOD Israeli Cancer Care Hospital, UkrainTitle: Real-time indocyanine green (ICG) fluorescence imaging technique for the detection of SLNs in early-stage breast cancerUhi Toh, Kurume University School of Medicine, JapanTitle: Proteomic profiling of plasma and tissue proteins associated to mammographic breast density using the KARMA cohortMarike Gabrielson, Karolinska Institutet, SwedenTitle: Breast cancer in young women-Retrospective studyJana Slobodnikova, Alexander Dubcek University of Trencin, SlovakiaTitle: E-MPBC-imaging findings of a rare aggressive breast cancer subtype: Metaplastic carcinoma of the breastHale Aydin, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Turkey
Lunch Break @ RestaurantYoung Researchers Forum
Title: Enhancement of radiosensitivity of human endothelial and breast cancer cells with melatonin by regulating angiogenesis and genes involved in estrogen biosynthesisAlicia González González, University of Cantabria, SpainTitle: Breast density in Chinese women: Using percentage and area measures from a quantitative techniqueTong Li, The University of Sydney, AustraliaTitle: Oncogenic protein kinase D regulating networks in invasive breast cancerYan Liu, Southeast University, ChinaTitle: Evaluation of diffusion weighted MR Imaging and 18F-FDG PET for monitoring triple negative breast cancer response to Cisplatin treatmentNguyen Thu Huong, Gunma University Graduate School of Medicine, Japan
Networking & Refreshments Break @ FoyerPoster Presentation @ Foyer
WCBC 001Title: Assessment of Breast Cancer occurrence among females at King Abdul Aziz Hospital, Al-Ahsa: A retrospective study from 2007-2014Eman M.G. Hassan, Cairo University, Egypt
WCBC 002Title: Radial scare- The Compar of Ultrasound Breast Imaging with Histopathology Slobodníková Jana, Alexander Dubček University in Trenčín, Slovakia
WCBC 003Title: Inhibition of the orphan nuclear receptor estrogen related receptor alpha sensitizes breast cancer cells to DNMT inhibitorsMathieu Vernier, McGill University, Canada
WCBC 004Title: Exploring the effects of an exercise programme on women with breast cancerRuth McCrea, St Margaret’s Hospital, United Kingdom
WCBC 005Title: Problems of mammary prosthesis inserted for a long period Shintaro Asai, Nagoya Kyoritsu Hospital, Japan
Panel Discussion and Award Ceremony Day 3 June 17, 2017
Extended Networking & Lunch @ Restaurant
Bookmark your dates
E: breastcancer@conferenceseries.netwww.breastcancer.conferenceseries.com/
May 10-11, 2018 Frankfurt, Germany
10th World Congress on
Breast Cancer